| Literature DB >> 23237281 |
C Schmitt1, M Matulic, M Kervégant, L Tichadou, A Boutin, M Glaizal, L de Haro.
Abstract
BACKGROUND: Emla(®) cream, a mixture of two local anaesthetics (prilocaine 2.5%, lidocaine 2.5%) has a good benefit-risk profile. However, methaemoglobinaemia can occur, especially when the cream is applied in excessive amounts or over long periods. PATIENTS AND METHODS: The authors report a case of seizure and respiratory disturbances (MetHb=20.1%) after excessive application of Emla(®) (30g) for curettage of molluscum contagiosum in a young girl with eczema. The patient's clinical condition improved after withdrawal of the cream and administration of methylene blue, and she returned home on day two. DISCUSSION: This new case of methaemoglobinaemia in a child following application of Emla(®) cream highlights the importance of strict compliance with the instructions for use of this medicinal product.Entities:
Mesh:
Substances:
Year: 2012 PMID: 23237281 DOI: 10.1016/j.annder.2012.06.035
Source DB: PubMed Journal: Ann Dermatol Venereol ISSN: 0151-9638 Impact factor: 0.777